Literature DB >> 7005425

Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.

P M Salzman, J A Salmon, S Moncada.   

Abstract

Superfused spiral strips of rabbit intrapulmonary artery (i.p.a.) were contracted by arachidonic acid (AA) and by the following substances in order of potency: prostaglandin (PG) endoperoxide analog (U46619) > PGH2 > PGF2 alpha. Intrapulmonary artery strips were consistently relaxed by PGE2 and by the enzyme inhibitors, indomethacin, aspirin, meclofenamic acid and 1-pentylimidazole. These latter inhibitors of cyclooxygenase and thromboxane (TX) synthetase also blocked the AA-induced contraction of rabbit i.p.a. Prostacyclin had no effect on the i.p.a. or produced either a small contraction or relaxation. TXA2, formed by incubating horse platelet microsomes with PHG2, always contracted the tissue and was more potent than the parent endoperoxide. Incubations of [14C]AA with i.p.a. produced mainly [14C]-6-keto-PGF1 alpha (he breakdonw product of prostacyclin ) and [14C]TXB2 (the breakdown product of TXA2); the identities of these products were confirmed by radioimmunoassay and by gas chromatography-mass spectrometry. The synthesis of TXB2 by i.p.a. cannot be attributed to adhering lung tissue or platelets and appears to be produced by the vascular tissue itself. It is concluded that, although both prostacyclin and thromboxane may contribute to the resting tone of the rabbit i.p.a., the response to AA is mainly due to production of TXA2.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005425

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.

Authors:  W L Salzer; C E McCall
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.

Authors:  M O Aksoy; C Harakal; J B Smith; G J Stewart; C R Zerweck
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

Review 3.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries.

Authors:  T Okamura; M Nakajima; N Toda
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

5.  The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels.

Authors:  U Förstermann; G Hertting; B Neufang
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

6.  Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid.

Authors:  H Bult; A G Herman; M Rampart
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

7.  Arterial eicosanoid production following chronic exposure to a periarterial haematoma.

Authors:  J D Pickard; V Walker; S Perry; P J Smythe; S Eastwood; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

8.  Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis.

Authors:  J L Mehta; D Lawson; P Mehta; T Saldeen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Pulmonary hypertensive response to declamping of the aorta during abdominal aortic reconstructive surgery-role of metabolic derangement and anaphylatoxin in the reaction.

Authors:  M Wakamatsu; Y Minamoto; F Okumura
Journal:  J Anesth       Date:  1990-01       Impact factor: 2.078

10.  Coronary vasoconstrictor and vasodilator actions of arachidonic acid in the isolated perfused heart of the rat.

Authors:  S E Belo; J Talesnik
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.